
Dan Leonard
Stock Analyst at RBC Capital
(4.81)
# 512
Out of 5,133 analysts
540
Total ratings
62.1%
Success rate
14.6%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintained: Hold | $73 | $72.83 | +0.23% | 23 | Nov 10, 2026 | |
| GH Guardant Health | Reiterated: Buy | $200 | $158.79 | +25.95% | 20 | Nov 6, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Hold | $1,515 → $1,790 | $1,762.28 | +1.57% | 16 | Nov 6, 2026 | |
| NTRA Natera | Reiterated: Buy | $460 | $320.39 | +43.58% | 21 | Nov 6, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $70 | $65.05 | +7.61% | 5 | Nov 5, 2026 | |
| BIO Bio-Rad Laboratories | Reiterated: Buy | $390 → $440 | $388.31 | +13.31% | 32 | Nov 4, 2026 | |
| GRAL GRAIL | Rated: Hold | $84 → $100 | $128.08 | -21.92% | 3 | Nov 4, 2026 | |
| RVTY Revvity | Rated: Hold | $135 → $172 | $160.72 | +7.02% | 20 | Nov 3, 2026 | |
| WAT Waters | Reiterated: Buy | $475 → $525 | $476.70 | +10.13% | 27 | Nov 3, 2026 | |
| RGEN Repligen | Reiterated: Buy | $200 | $178.94 | +11.77% | 7 | Nov 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $310 | $220.78 | +40.41% | 44 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 → $17 | $15.91 | +6.85% | 14 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $580 → $730 | $721.63 | +1.16% | 29 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $265 | $235.12 | +12.71% | 29 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 → $185 | $180.17 | +2.68% | 36 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $66.54 | -32.37% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $10 | $12.22 | -18.17% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $175 | $353.34 | -50.47% | 19 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $355 → $340 | $413.09 | -17.69% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $52 | $50.55 | +2.87% | 17 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $240 | $278.84 | -13.93% | 17 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $13 | $20.47 | n/a | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $220 | $207.59 | n/a | 7 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $28 | $13.73 | n/a | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $300 → $305 | $672.93 | n/a | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $26.15 | n/a | 6 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $8.02 | n/a | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 → $7 | $30.26 | n/a | 2 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 → $320 | $371.83 | n/a | 15 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $160 → $145 | $259.67 | n/a | 15 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $95 | $135.42 | n/a | 7 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.0001 | n/a | 1 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $35 | $5.74 | n/a | 14 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $215.25 | n/a | 1 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.01 | n/a | 5 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $84.42 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.92 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $110.51 | n/a | 1 | Jun 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.000001 | n/a | 4 | May 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.5 | $0.8007 | n/a | 3 | May 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $0.6942 | n/a | 11 | Apr 12, 2016 |
Bio-Techne
Nov 10, 2026
Maintained: Hold
Price Target: $73
Current: $72.83
Upside: +0.23%
Guardant Health
Nov 6, 2026
Reiterated: Buy
Price Target: $200
Current: $158.79
Upside: +25.95%
Mettler-Toledo International
Nov 6, 2026
Reiterated: Hold
Price Target: $1,515 → $1,790
Current: $1,762.28
Upside: +1.57%
Natera
Nov 6, 2026
Reiterated: Buy
Price Target: $460
Current: $320.39
Upside: +43.58%
10x Genomics
Nov 5, 2026
Reiterated: Hold
Price Target: $70
Current: $65.05
Upside: +7.61%
Bio-Rad Laboratories
Nov 4, 2026
Reiterated: Buy
Price Target: $390 → $440
Current: $388.31
Upside: +13.31%
GRAIL
Nov 4, 2026
Rated: Hold
Price Target: $84 → $100
Current: $128.08
Upside: -21.92%
Revvity
Nov 3, 2026
Rated: Hold
Price Target: $135 → $172
Current: $160.72
Upside: +7.02%
Waters
Nov 3, 2026
Reiterated: Buy
Price Target: $475 → $525
Current: $476.70
Upside: +10.13%
Repligen
Nov 1, 2026
Reiterated: Buy
Price Target: $200
Current: $178.94
Upside: +11.77%
Oct 29, 2026
Reiterated: Buy
Price Target: $310
Current: $220.78
Upside: +40.41%
Oct 28, 2026
Rated: Hold
Price Target: $14 → $17
Current: $15.91
Upside: +6.85%
Oct 22, 2026
Rated: Hold
Price Target: $580 → $730
Current: $721.63
Upside: +1.16%
Oct 21, 2026
Reiterated: Buy
Price Target: $250 → $265
Current: $235.12
Upside: +12.71%
Aug 26, 2026
Reiterated: Buy
Price Target: $153 → $185
Current: $180.17
Upside: +2.68%
May 7, 2026
Rated: Hold
Price Target: $40 → $45
Current: $66.54
Upside: -32.37%
Mar 9, 2026
Rated: Buy
Price Target: $15 → $10
Current: $12.22
Upside: -18.17%
Feb 25, 2026
Reiterated: Hold
Price Target: $170 → $175
Current: $353.34
Upside: -50.47%
Feb 13, 2026
Reiterated: Buy
Price Target: $355 → $340
Current: $413.09
Upside: -17.69%
Feb 9, 2026
Reiterated: Hold
Price Target: $52
Current: $50.55
Upside: +2.87%
Feb 6, 2026
Reiterated: Buy
Price Target: $280 → $240
Current: $278.84
Upside: -13.93%
Nov 5, 2025
Reiterated: Buy
Price Target: $11 → $13
Current: $20.47
Upside: n/a
Oct 24, 2025
Reiterated: Buy
Price Target: $260 → $220
Current: $207.59
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $24 → $28
Current: $13.73
Upside: n/a
Jul 29, 2025
Downgraded: Sell
Price Target: $300 → $305
Current: $672.93
Upside: n/a
Mar 2, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $26.15
Upside: n/a
Aug 8, 2024
Reiterated: Hold
Price Target: $11
Current: $8.02
Upside: n/a
Feb 14, 2023
Reiterated: Sell
Price Target: $8 → $7
Current: $30.26
Upside: n/a
Feb 11, 2022
Reiterated: Buy
Price Target: $340 → $320
Current: $371.83
Upside: n/a
Feb 4, 2022
Reiterated: Hold
Price Target: $160 → $145
Current: $259.67
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $86 → $95
Current: $135.42
Upside: n/a
Jul 14, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
Aug 14, 2019
Reiterated: Hold
Price Target: $45 → $35
Current: $5.74
Upside: n/a
Dec 6, 2018
Initiated Coverage: Buy
Price Target: $280
Current: $215.25
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $7
Current: $0.01
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $84.42
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $25.92
Upside: n/a
Jun 16, 2016
Rated: Hold
Price Target: n/a
Current: $110.51
Upside: n/a
May 23, 2016
Reiterated: Buy
Price Target: $4
Current: $0.000001
Upside: n/a
May 11, 2016
Reiterated: Hold
Price Target: $4.5 → $3.5
Current: $0.8007
Upside: n/a
Apr 12, 2016
Reiterated: Buy
Price Target: $20 → $15
Current: $0.6942
Upside: n/a